Chlorophenoxyisobutyricacidethylester en es it fr

Chlorophenoxyisobutyricacidethylester Brand names, Chlorophenoxyisobutyricacidethylester Analogs

Chlorophenoxyisobutyricacidethylester Brand Names Mixture

  • No information avaliable

Chlorophenoxyisobutyricacidethylester Chemical_Formula

C26H28N2

Chlorophenoxyisobutyricacidethylester RX_link

No information avaliable

Chlorophenoxyisobutyricacidethylester fda sheet

Chlorophenoxyisobutyricacidethylester msds (material safety sheet)

Chlorophenoxyisobutyricacidethylester Synthesis Reference

No information avaliable

Chlorophenoxyisobutyricacidethylester Molecular Weight

368.514 g/mol

Chlorophenoxyisobutyricacidethylester Melting Point

No information avaliable

Chlorophenoxyisobutyricacidethylester H2O Solubility

750 mg/L

Chlorophenoxyisobutyricacidethylester State

Solid

Chlorophenoxyisobutyricacidethylester LogP

5.63

Chlorophenoxyisobutyricacidethylester Dosage Forms

No information avaliable

Chlorophenoxyisobutyricacidethylester Indication

For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.

Chlorophenoxyisobutyricacidethylester Pharmacology

Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.

Chlorophenoxyisobutyricacidethylester Absorption

No information avaliable

Chlorophenoxyisobutyricacidethylester side effects and Toxicity

No information avaliable

Chlorophenoxyisobutyricacidethylester Patient Information

No information avaliable

Chlorophenoxyisobutyricacidethylester Organisms Affected

Humans and other mammals